Eun-Hyun Jang

Title: Eun-Hyun Jang: Innovator in Drug Delivery Systems

Introduction

Eun-Hyun Jang is a notable inventor based in Cambridge, MA (US). She has made significant contributions to the field of drug delivery systems, particularly through her innovative approaches to enhancing the bioavailability of therapeutic agents.

Latest Patents

Eun-Hyun Jang holds a patent for "Stabilized reverse micelle compositions and uses thereof." This invention focuses on compositions and methods for drug delivery that promote the transmucosal absorption of drugs, especially those with poor intrinsic bioavailability, such as peptides, proteins, vaccines, and nucleic acids. The delivery system comprises fatty acid esters and their hydrophilic derivatives, which form reverse micelles that are physically stabilized in the presence of gastrointestinal fluid and other polar solvents. These stable reverse micelles allow for delayed drug release profiles and sustained absorption, protecting therapeutic molecules from degradation and facilitating their uptake by absorptive cells.

Career Highlights

Eun-Hyun Jang is currently associated with Soligenix, Inc., where she continues to advance her research in drug delivery technologies. Her work has the potential to significantly impact the pharmaceutical industry by improving the efficacy of various therapeutic agents.

Collaborations

Eun-Hyun has collaborated with notable colleagues, including Panayiotis P Constantinides and Likan Liang, contributing to a dynamic research environment that fosters innovation.

Conclusion

Eun-Hyun Jang's contributions to drug delivery systems exemplify the importance of innovation in enhancing therapeutic efficacy. Her work continues to pave the way for advancements in the field, making a meaningful impact on healthcare.